Physicians’ gender and specialty in relation to adverse drug reaction reporting in Sweden

Abstract Purpose To evaluate the possible influence of gender and specialty on adverse drug reaction (ADR) reporting among physicians before and after the COVID-19 pandemic. Methods This retrospective nationwide register study analysed all ADR reports submitted by physicians to the Swedish Medical Products Agency during 2017 and 2023 ( n = 4079 and 3740, respectively). The reporting rates were calculated and stratified by gender and specialty. Results The highest reporting rate among physicians